Moneycontrol PRO
HomeNewsMangalam drugs & organics

Mangalam Drugs

Jump to
  • Mangalam Drugs Standalone June 2025 Net Sales at Rs 57.35 crore, down 25.07% Y-o-Y

  • Mangalam Drugs Standalone March 2025 Net Sales at Rs 73.04 crore, down 28.56% Y-o-Y

    Mangalam Drugs Standalone March 2025 Net Sales at Rs 73.04 crore, down 28.56% Y-o-Y

  • Mangalam Drugs Consolidated December 2024 Net Sales at Rs 88.71 crore, down 8.86% Y-o-Y

    Mangalam Drugs Consolidated December 2024 Net Sales at Rs 88.71 crore, down 8.86% Y-o-Y

  • Mangalam Drugs Standalone September 2024 Net Sales at Rs 79.94 crore, down 1.98% Y-o-Y

    Mangalam Drugs Standalone September 2024 Net Sales at Rs 79.94 crore, down 1.98% Y-o-Y

  • Mangalam Drugs Standalone June 2024 Net Sales at Rs 76.54 crore, down 12.5% Y-o-Y

    Mangalam Drugs Standalone June 2024 Net Sales at Rs 76.54 crore, down 12.5% Y-o-Y

  • Mangalam Drugs Consolidated March 2024 Net Sales at Rs 102.24 crore, up 0% Y-o-Y

    Mangalam Drugs Consolidated March 2024 Net Sales at Rs 102.24 crore, up 0% Y-o-Y

  • Mangalam Drugs Standalone March 2024 Net Sales at Rs 102.24 crore, up 12.21% Y-o-Y

    Mangalam Drugs Standalone March 2024 Net Sales at Rs 102.24 crore, up 12.21% Y-o-Y

  • Mangalam Drugs Standalone December 2023 Net Sales at Rs 97.34 crore, up 53.7% Y-o-Y

    Mangalam Drugs Standalone December 2023 Net Sales at Rs 97.34 crore, up 53.7% Y-o-Y

  • Mangalam Drugs Standalone September 2023 Net Sales at Rs 81.56 crore, down 24.71% Y-o-Y

    Mangalam Drugs Standalone September 2023 Net Sales at Rs 81.56 crore, down 24.71% Y-o-Y

  • Mangalam Drugs Standalone June 2023 Net Sales at Rs 87.47 crore, down 20.12% Y-o-Y

    Mangalam Drugs Standalone June 2023 Net Sales at Rs 87.47 crore, down 20.12% Y-o-Y

  • Mangalam Drugs Standalone March 2023 Net Sales at Rs 91.11 crore, down 24.68% Y-o-Y

    Mangalam Drugs Standalone March 2023 Net Sales at Rs 91.11 crore, down 24.68% Y-o-Y

  • Mangalam Drugs Standalone December 2022 Net Sales at Rs 63.33 crore, down 32.51% Y-o-Y

    Mangalam Drugs Standalone December 2022 Net Sales at Rs 63.33 crore, down 32.51% Y-o-Y

  • Mangalam Drugs Standalone September 2022 Net Sales at Rs 108.33 crore, down 5.15% Y-o-Y

    Mangalam Drugs Standalone September 2022 Net Sales at Rs 108.33 crore, down 5.15% Y-o-Y

  • Mangalam Drugs Standalone June 2022 Net Sales at Rs 109.49 crore, up 4.5% Y-o-Y

    Mangalam Drugs Standalone June 2022 Net Sales at Rs 109.49 crore, up 4.5% Y-o-Y

  • Mangalam Drugs Standalone March 2022 Net Sales at Rs 120.96 crore, up 33.23% Y-o-Y

    Mangalam Drugs Standalone March 2022 Net Sales at Rs 120.96 crore, up 33.23% Y-o-Y

  • Mangalam Drugs Standalone December 2021 Net Sales at Rs 93.84 crore, up 5.81% Y-o-Y

    Mangalam Drugs Standalone December 2021 Net Sales at Rs 93.84 crore, up 5.81% Y-o-Y

  • Mangalam Drugs Standalone June 2021 Net Sales at Rs 104.78 crore, up 1.1% Y-o-Y

    Mangalam Drugs Standalone June 2021 Net Sales at Rs 104.78 crore, up 1.1% Y-o-Y

  • Mangalam Drugs Standalone June 2020 Net Sales at Rs 103.64 crore, up 59.34% Y-o-Y

    Mangalam Drugs Standalone June 2020 Net Sales at Rs 103.64 crore, up 59.34% Y-o-Y

  • Mangalam Drugs Standalone March 2020 Net Sales at Rs 88.09 crore, up 83.19% Y-o-Y

    Mangalam Drugs Standalone March 2020 Net Sales at Rs 88.09 crore, up 83.19% Y-o-Y

  • Mangalam Drugs Standalone December 2019 Net Sales at Rs 61.94 crore, up 27.5% Y-o-Y

    Mangalam Drugs Standalone December 2019 Net Sales at Rs 61.94 crore, up 27.5% Y-o-Y

  • Mangalam Drugs Standalone June 2019 Net Sales at Rs 65.04 crore, up 10.23% Y-o-Y

    Mangalam Drugs Standalone June 2019 Net Sales at Rs 65.04 crore, up 10.23% Y-o-Y

  • Mangalam Drugs Standalone March 2019 Net Sales at Rs 48.09 crore, down 28.43% Y-o-Y

    Mangalam Drugs Standalone March 2019 Net Sales at Rs 48.09 crore, down 28.43% Y-o-Y

  • Mangalam Drugs Standalone December 2018 Net Sales at Rs 48.58 crore, down 34.27% Y-o-Y

    Mangalam Drugs Standalone December 2018 Net Sales at Rs 48.58 crore, down 34.27% Y-o-Y

  • Mangalam Drugs Standalone September 2018 Net Sales at Rs 71.90 crore, down 13.56% Y-o-Y

    Mangalam Drugs Standalone September 2018 Net Sales at Rs 71.90 crore, down 13.56% Y-o-Y

  • Mangalam Drugs, NOCIL up 3-4% on strong Q4 numbers

    Mangalam Drugs, NOCIL up 3-4% on strong Q4 numbers

    NOCIL has registered 13.3 percent increase in its Q4 net profit at Rs 25.5 crore versus Rs 22.5 crore.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347